Schisandrin B

Schisandrin B has been studied in 2 papers since 2023: none in people yet, 2 in animals. The research so far is in animals. The newest paper, Oct 17, 2025: “Schisandrin B combined with vitamin D inhibits NLRP3 inflammasome to improve cognitive dysfunction and Alzheimer's disease”.

Intervention

2 papers study it4 findingsUpdated

PubChem

See all 2 papers on schisandrin B

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: National College Students Innovation and Entrepreneurship Training Program and 1 more
  • Animals2

What did studies of schisandrin B find?

4

Studies of schisandrin B measured 4 outcomes, among them senescence-associated beta-galactosidase, cellular senescence and hepatic collagen deposition.

Senescence-associated beta-galactosidase

upin human cells1

1 study
  1. Schisandrin B increases senescence-associated beta-galactosidase in human cells.

    Cells20 μM24 h

More on Senescence-associated beta-galactosidase

Cellular senescence

upin mice1

1 study
  1. Schisandrin B induces cellular senescence in mice.

    Animals40 mg/kg30 d

More on Cellular senescence

Hepatic collagen deposition

downin mice1

1 study
  1. Schisandrin B decreases hepatic collagen deposition in mice.

    Animals40 mg/kg30 d

AST

downin mice1

1 study
  1. Schisandrin B decreases AST in mice (AST -53.2%, ALT -63.6%).

    Animals40 mg/kg30 d

More on AST

Latest